Comparative proteomics analysis of human gastric cancer

Table 1 Clinical-pathological characters of 10 gastric cancer patients

Age	Sex	Cell type	Stage	Bommann type
51	M	Moderate	T3N1M0	II
68	M	Moderate	T3N1M1	III
53	M	Poor with signet ring	T3N3M0	II
49	F	Poor	T3N1M0	II
75	F	Moderate	T3N1M0	I
40	M	Poor	T3N2M0	III
62	M	Poor with signet ring	T3N1M0	II
74	M	Poor with signet ring	T3N1M0	II
78	M	Poor with signet ring	T3N1M0	III
67	F	Poor	T3N2M0	III

Table 2 Over-expressed proteins in human gastric cancer

Spot ID	Protein name	Accession number1	Top score	Theoretic pI	Theoretic Mr (Da)
T1	Bullous pemphigoid antigen1 isoforms 1/2/3/4/5/8	Q03001	85	6.38	371 977
T2	Ras-related protein Rab-30	Q15771	64	4.91	23 058
T3	Zinc finger protein 268	Q14587	57	9.14	108 373
T4	Calcium-binding protein CaBP5	Q9NP86	61	4.46	19 812
T5	RGS3	P49796	62	4.79	56 566
T61	MAGUK p55 subfamily member 3	Q13368	45	6.27	66 168
T7	Zinc finger protein 134	P52741	57	9.18	40 297
T81	Actin, alpha cardiac	P04270	154	5.23	42 019
T9	Nebulin	P20929	59	9.10	772 727
T10	Vacuolar protein sorting 33B	Q9H267	54	6.29	70 570

¹Accession number from SWISS-PROT database, identified by MALDI-TOF-TOF-MS.

Table 3 Under-expressed proteins in human gastric cancer

Spot ID	Protein name	Accession number1	Top score	Theoretic pI	Theoretic Mr (Da)
N11	Peroxiredoxin 2	P32119	72	5.66	21 892
N21	Zinc finger protein ZFP-36	P16415	44	8.99	66 683
N3	Zinc finger protein 64, isoforms 3 and 4	Q9NTW7	58	8.80	72 216
N4	Bullous pemphigoid antigen 1, isoforms 6/9/10	O94833	62	5.50	590 528
N5	Transcriptional repressor CTCFL	Q8NI51	67	8.58	75 668

¹Accession number from SWISS-PROT database, identified by MALDI-TOF-TOF-MS.